Managing diabetic nephropathy

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 10, Issue 5, 2010, Pages 500-504

  Shields, Joanne ^a   Maxwell, Alexander P ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FISH OIL; HEMOGLOBIN A1C; MEGLITINIDE; METFORMIN; SULFONYLUREA;

BLOOD GLUCOSE MONITORING; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ETHNICITY; GENETIC SUSCEPTIBILITY; HYPERTENSION; INSULIN RESISTANCE; MICROALBUMINURIA; PATHOGENESIS; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY; SMOKING; ULTRASOUND;

EID: 78650354005     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.10-5-500     Document Type: Short Survey

References (14)

1. The United States Renal Data System (USRDS): Annual data report 2009. www.usrds.org/adr.htm
2. The United Kingdom Renal Registry (UKRR). Annual data report 2009. www.renalreg.com/Reports/2009.html
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
4. Lurbe E, Redon J, Kesani A et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002;347:797-805. (Pubitemid 34988338)
5. Magee GM, Bilous RW, Cardwell CR et al. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009;52:691-7.
6. Adler AI, Stevens RJ,Manley SE et al; UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-32.
7. Hallan S, Astor B, Romundstad S et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Int Med 2007;167:2490-6. (Pubitemid 350254909)
8. National Institute for Health and Clinical Excellence. Management of type 2 diabetes. London: NICE, 2008.
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
10. Yusuf S, Teo KK, Pogue J et al; ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-59. (Pubitemid 351522739)
11. Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study investigators. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 2008;358:2433-46.
12. Bakris GL,Williams M, Dworkin L et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000;36:646-61.
13. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91. (Pubitemid 351214285)
14. National Institute for Health and Clinical Excellence. Management of chronic kidney disease. London: NICE, 2008.